1472
H. Ishibashi et al. / Tetrahedron 56 (2000) 1469–1473
of 6, aniline 14 (127.6 mg, 0.59 mmol) was treated with
pyruvyl chloride (92.3 mg, 0.87 mmol) in the presence of
pyridine (81.6 mg, 0.97 mmol) in CH2Cl2 (3 ml). After
work-up, the crude material was chromatographed on silica
gel (hexane–AcOEt, 2:1) to give 15 (157.2 mg, 93%) as an
oil: IR (CHCl3) n 1720, 1655 cmϪ1; 1H NMR (270 MHz) d
2.30 (3 H, s), 3.24 (3 H, s), 3.81 (3 H, s), 6.85 (1 H, dd,
J8.6, 3.0 Hz), 7.12 (1 H, d, J3.0 Hz), 7.22 (1 H, d,
J8.6 Hz). Anal. Calcd for C11H12BrNO3: C, 46.18; H,
4.23; N, 4.90. Found: C, 45.94; H, 4.27; N, 4.76.
described above for the preparation of 8, compound 17
(105.3 mg, 0.31 mmol) was treated with Bu3SnH
(114.2 mg, 0.39 mmol) in the presence of AIBN (6.2 mg,
0.04 mmol) in benzene (45 ml). After work-up, the crude
material was chromatographed on silica gel (hexane–
AcOEt, 1:1) to give 4 (70.1 mg, 87%), mp 83–84ЊC (from
AcOEt–petroleum ether) (lit.13 mp 83–84ЊC): IR (CHCl3) n
1740, 1700 cmϪ1; 1H NMR (270 MHz) d 1.37 (3 H, s), 2.82
(1 H, d, J16.5 Hz), 3.00 (1 H, d, J16.5 Hz), 3.23 (3 H, s),
3.48 (3 H, s), 3.79 (3 H, s), 6.75–6.85 (3 H, m).
20-Bromo-40-methoxy-N-methyl-3-cyano-2-methylpro-
penanilide (16). Using a procedure similar to that described
above for the preparation of 7, diethylphosphonoacetonitrile
(90.1 mg, 0.53 mmol) was treated with BuLi (1.57 M
hexane solution) (0.3 ml, 0.47 mmol) and then with
compound 15 (107.1 mg, 0.38 mmol). After work-up, the
crude material was chromatographed on silica gel (hexane–
AcOEt, 1:1) to give 16 (82.8 mg, 72%) as an oily mixture of
two isomers in a ratio of ca. 9:5: IR (CHCl3) n 2225,
Acknowledgements
This work was supported by a Grant-in-Aid for Scientific
Research from the Ministry of Education, Science, Sports
and Culture of Japan.
References
1
1650 cmϪ1; H NMR (270 MHz) d 1.93 (5/14×3 H, d,
J1.7 Hz), 2.05 (9/14×3 H, d, J1.3 Hz), 3.23 (9/14×3
H, s), 3.29 (5/14×3 H, s), 3.83 (5/14×3 H, s), 3.84 (9/
14×3H, s), 5.11 (5/14 H, q, J1.7 Hz), 5.40 (9/14 H, q,
J1.3 Hz), 6.80–7.20 (2ϩ9/14 H, m), 7.52 (5/14 H, d,
J8.6 Hz). Anal. Calcd for C13H13BrN2O2: C, 50.51; H,
4.24; N, 9.06. Found: C, 50.29; H, 4.35; N, 8.90.
1. Takano, S.; Ogasawara, K. The Alkaloids 1989, 36, 225.
2. Brossi, A. J. Med. Chem. 1990, 33, 2311.
3. Grieg, N. H.; Pei, X.-F.; Soncrant, T. T.; Ingram, D. K.; Brossi,
A. Med. Res. Rev. 1995, 15, 3.
4. Julian, P. L.; Pikl, J. J. Am. Chem. Soc. 1935, 57, 563 (see also
p. 755).
5. For syntheses of racemic and optically acitive 3 and their
5-alkoxy derivatives, see (a) Robinson, B. J. Chem. Soc. 1965,
3336. (b) Lee, T. B. K.; Wong, G. S. K. J. Org. Chem. 1991, 56,
872. (c) Yu, Q.-S.; Luo, W.-M.; Li, Y.-Q.; Brossi, A. Heterocycles
1993, 36, 1279. (d) Yu, Q.-S.; Lu, B.-Y.; Pei, X.-F. Heterocycles
1994, 39, 519. (e) Pei, X.-F.; Bi, S. Heterocycles 1994, 39, 357. (f)
Pallavicini, M.; Valoti, E.; Villa, L.; Lianza, F. Tetrahedron:
Asymmetry 1994, 5, 111. (g) Pei, X.-F.; Brossi, A. Heterocycles
Methyl 3-(20-Bromo-40-methoxyphenyl-N-methylcarba-
moyl)-3-methyl-2-butenoate (17). Using a procedure
similar to that described above for the preparation of 7,
methyl dimethylphosphonoacetate (84.5 mg, 0.46 mmol)
was treated with BuLi (1.50 M hexane solution) (0.3 ml,
0.45 mmol) and then with compound 15 (100.1 mg,
0.35 mmol). After work-up, the crude material was chromato-
graphed on silica gel (hexane–AcOEt, 1:1) to give 17
(105.3 mg, 88%) as an oily mixture of three isomers in a
ratio of ca. 10:5:3: IR (CHCl3) n 1715, 1640 cmϪ1; 1H NMR
(270 MHz) d 1.85 (10/18×3 H, d, J1.5 Hz), 2.14 (5/18×3
H, d, J1.5 Hz), 2.22 (3/18×3 H, d, J1.5 Hz), 3.16 (3/
18×3 H, s), 3.23 (5/18×3 H, s), 3.28 (10/18×3 H, s), 3.63
(5/18×3 H, s), 3.76 (13/18×3 H, s), 3.81 (3 H, s), 5.55 (10/18
H, q, J1.5 Hz), 5.87 (3/18 H, q, J1.5 Hz), 5.90 (5/18 H,
´
1995, 41, 2823. (h) Morales-Rıos, M. S.; Bucio, M. A.; Joseph-
Nathan, P. Tetrahedron 1996, 52, 5339.
6. Yu, Q.-S.; Brossi, A. Heterocycles 1988, 27, 1709. See also
Refs. 5b, 5e and 5f.
7. Kihara, M.; Iwai, Y.; Nagao, Y. Heterocycles 1995, 41, 2279.
8. Ottenheijm, H. C. J.; de Man, J. H. M. Synthesis 1975, 163.
9. Jones, K.; Thompson, M.; Wright, C. J. Chem. Soc., Chem.
Commun. 1986, 115; Clark, A. J.; Jones, K. Tetrahedron Lett.
1989, 30, 5485; Jones, K.; Storey, J. M. D. J. Chem. Soc., Chem.
Commun. 1992, 1766; Jones, K.; Wilkinson, J.; Ewin, R.
Tetrahedron Lett. 1994, 35, 7673; Cossy, J.; Cases, M.; Pardo,
D. G. Tetrahedron Lett. 1998, 39, 2331; Jones, K.; Brunton,
S. A.; Gosain, R. Tetrahedron Lett. 1999, 40, 8935.
10. (a) Clark, A. J.; Davies, D. I.; Jones, K.; Millbanks, C. J. Chem.
Soc., Chem. Commun. 1994, 41. (b) Cabri, W.; Candiani, I.;
Colombo, M.; Franzoi, L.; Bedeschi, A. Tetrahedron Lett. 1995,
36, 949.
11. Jones reported that anilide I, upon treatment with Co(I)–salen
complex, gave a mixture of the 5-exo cyclization product II and the
6-endo cyclization product III in a ratio of 3:1 and in 40%
combined yield.12 The product II was converted into IV, the inter-
mediate for the synthesis of physovenine (2) (Scheme 5).
12. Clark, A. J.; Jones, K. Tetrahedron 1992, 48, 6875.
13. Luo, Y.-L.; Yu, Q.-S.; Chrisey, L.; Brossi, A. Heterocycles
1990, 31, 283.
q, J1.5 Hz), 6.70–7.60 (3 H, m). HRMS Calcd for
79
C14H BrNO4: 341.0263. Found: 341.0275.
16
2,3-Dihydro-5-methoxy-1,3-dimethyl-2-oxo-1H-indole-3-
acetonitrile (3). Using a procedure similar to that described
above for the preparation of 8, compound 16 (99.2 mg,
0.32 mmol) was treated with Bu3SnH (114.6 mg,
0.39 mmol) in the presence of AIBN (6.4 mg, 0.04 mmol)
in benzene (48 ml). After work-up, the crude material was
chromatographed on silica gel (hexane–AcOEt, 1:1) to give
3 (72.3 mg, 98%), mp 71–73ЊC (from Et2O–hexane) (lit.5h
1
mp 70–72ЊC): IR (CHCl3) n 2255, 1710 cmϪ1; H NMR
(270 MHz) d 1.52 (3 H, s), 2.55 (1 H, d, J16.5 Hz), 2.84
(1 H, d, J16.5 Hz), 3.22 (3 H, s), 3.82 (3 H, s), 6.81 (1 H, d,
J8.6 Hz), 6.86 (1 H, dd, J8.6, 2.0 Hz), 7.09 (1 H, d,
1
J2.0 Hz). The H NMR spectral data were identical with
those reported.5f
14. For total or formal syntheses of (Ϫ)-physostigmine, see (a)
Takano, S.; Goto, E.; Hirama, M.; Ogasawara, K. Chem Pharm.
Bull. 1982, 30, 2641. (b) Takano, S.; Moriya, M.; Iwabuchi, Y.;
Methyl 2,3-dihydro-5-methoxy-1,3-dimethyl-2-oxo-1H-
indole-3-acetate (4). Using a procedure similar to that